LRPAP1 and breast cancer: No significant change in proliferation of MDA-MB-231 cells was found after GST-RAP treatment (Figure 4A and Supplementary Figure 5B), indicating that ligand-independent activities may be involved in VLDLR-mediated promotion of breast cancer cell growth.